Biological Testing Facility Access For Contraceptive Development (X01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The NICHD has a state-of-the art Biological Testing Facility for advancing male and/or female non-hormonal contraception development with the capabilities and capacity for preclinical and Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., fertility studies, pharmacology, toxicology, reproductive tract histopathology, sperm morphology).

The purpose of this FOA is to provide investigators with a mechanism to request services from this facility that would advance their contraceptive development program.


  • Letter of Intent Due Date(s): 30 days before application due date.
  • Application Due Date(s): July 1, 2019, December 16, 2019, May 1, 2020


PAR-19-263 Expiration Date: May 02, 2020

Agency Website

Amount Description

Award Budget: Not Applicable; there is no budget associated with X01 Resource Access Awards.

Funding Type





Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 1, 2020